Influence of hyperthyroidism on the kinetics of methimazole, propranolol, metoprolol and atenolol.
The kinetic profiles of oral methimazole 40 mg, propranolol 80 mg, metoprolol 100 mg and atenolol 100 mg were compared in hyperthyroid patients both during the hyper- and euthyroid states. for methimazole, neither the peak concentration (Cmax), the time to reach peak concentration (tmax), the elimination half-life (t 1/2) nor the area under the curve (AUC) value was affected by the hyperthyroid state. For propranolol and metoprolol, which undergo extensive presystemic clearance, the AUC values were lower (p less than 0.02) when the patients were hyperthyroid than when they had become euthyroid, but the t 1/2's were not significantly altered. For atenolol, there were no significant kinetic differences between the hyperthyroid and euthyroid states. The findings are compatible with the assumption that hyperthyroidism does not affect the kinetics of methimazole or atenolol, but that it may enhance presystemic clearance of propranolol and metoprolol.
D000284:Administration, Oral; D001262:Atenolol / Q000097:blood*; D005260:Female; D006801:Humans; D006980:Hyperthyroidism / Q000378:metabolism*; D007700:Kinetics; D008297:Male; D008657:Metabolic Clearance Rate; D008713:Methimazole / Q000097:blood*; D008790:Metoprolol / Q000097:blood*; D008875:Middle Aged; D011412:Propanolamines / Q000097:blood*; D011433:Propranolol / Q000097:blood*
D011412:Propanolamines; D001262:Atenolol; D008713:Methimazole; D011433:Propranolol; D008790:Metoprolol